CORMEDIX INC. Operating Lease Right-of-Use Assets
CORMEDIX INC. (CRMD) had Operating Lease Right-of-Use Assets of $3.02 million as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-03-05
- 2025-12-31: Operating Lease, Right-of-Use Asset $3.02M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $3.17M.
- 2025-06-30: Operating Lease, Right-of-Use Asset $413.65K.
- 2025-03-31: Operating Lease, Right-of-Use Asset $453.63K.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2025-12-31 | $3.02M 10-K · filed 2026-03-05 | |
| 2025-09-30 | $3.17M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $413.65K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $453.63K 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $493.00K 10-K · filed 2026-03-05 | $492.70K 10-K · filed 2025-03-25 |
| 2024-09-30 | $530.86K 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $568.17K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $604.63K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $640.28K 10-K · filed 2025-03-25 | |
| 2023-09-30 | $675.12K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $709.18K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $742.50K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $775.09K 10-K · filed 2024-03-12 | |
| 2022-09-30 | $806.95K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $838.12K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $869.15K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $899.50K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $929.21K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $958.28K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $986.76K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.01M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $1.04M 10-Q · filed 2020-11-05 | |
| 2019-12-31 | $4.69K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $5.00K 10-Q · filed 2019-11-14 | |
| 2019-01-02 | $6.00K 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |